Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B

[1]  Kui Liu,et al.  Environmental Research and Public Health Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic Hbv-infected Chinese: a Meta-analysis , 2022 .

[2]  S. Alavian,et al.  Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections , 2016, Hepatitis monthly.

[3]  Lei Li,et al.  The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus , 2016, Lipids in Health and Disease.

[4]  Min Hu,et al.  High apolipoprotein M serum levels correlate with chronic obstructive pulmonary disease , 2016, Lipids in Health and Disease.

[5]  S. Swendeman,et al.  Impaired endothelial barrier function in apolipoprotein M‐deficient mice is dependent on sphingosine‐1‐phosphate receptor 1 , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  T. Tsai,et al.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. , 2016, World journal of gastroenterology.

[7]  G. Luo,et al.  Decreased Splenic CD4+ T-Lymphocytes in Apolipoprotein M Gene Deficient Mice , 2015, BioMed research international.

[8]  R. Proia,et al.  HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation , 2015, Science Signaling.

[9]  R. Proia,et al.  HDL-bound sphingosine 1-phosphate restrains lymphopoiesis and neuroinflammation , 2015, Nature.

[10]  Xiaobei Wang,et al.  Investigation into the effect of hepatitis B virus on apoliprotein A1 expression and its mechanism , 2014, Lipids in Health and Disease.

[11]  Lei Zheng,et al.  Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1α-dependent manner. , 2013, Archives of biochemistry and biophysics.

[12]  J. Hoover-Plow,et al.  Lipoprotein(a) metabolism: potential sites for therapeutic targets. , 2013, Metabolism: clinical and experimental.

[13]  Adam Linder,et al.  Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes , 2012, Critical Care.

[14]  P. Nilsson-ehle,et al.  TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells , 2011, Lipids in Health and Disease.

[15]  F. Liu,et al.  Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication , 2011, Lipids in Health and Disease.

[16]  A. Hoofnagle,et al.  Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. , 2011, Atherosclerosis.

[17]  Jiann-Ruey Hong,et al.  Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus X protein in zebrafish. , 2010, Biochimica et biophysica acta.

[18]  N. Xu,et al.  Impaired plasma lipid profiles in acute hepatitis , 2010, Lipids in Health and Disease.

[19]  Y. Shin,et al.  Liver X receptor mediates hepatitis B virus X protein–induced lipogenesis in hepatitis B virus–associated hepatocellular carcinoma , 2009, Hepatology.

[20]  G. Kostner,et al.  LXR-agonists regulate ApoM expression differentially in liver and intestine. , 2008, Current pharmaceutical biotechnology.

[21]  Jingting Jiang,et al.  Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases , 2008, Lipids in Health and Disease.

[22]  B. Porse,et al.  Effect of Apolipoprotein M on High Density Lipoprotein Metabolism and Atherosclerosis in Low Density Lipoprotein Receptor Knock-out Mice* , 2008, Journal of Biological Chemistry.

[23]  Nyein Nyein Ei,et al.  Serum leptin concentrations in chronic hepatitis. , 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[24]  M. N. Poy,et al.  Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis , 2005, Nature Medicine.

[25]  P. Nilsson-ehle,et al.  Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo. , 2004, Biochemical and biophysical research communications.

[26]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[27]  M. Thursz.  Genetic susceptibility in chronic viral hepatitis. , 2001, Antiviral research.

[28]  K. Feingold,et al.  Infection and inflammation-induced proatherogenic changes of lipoproteins. , 2000, The Journal of infectious diseases.

[29]  B. Dahlbäck,et al.  A Novel Human Apolipoprotein (apoM)* , 1999, The Journal of Biological Chemistry.

[30]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[31]  P. Clifton,et al.  Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. , 1985, Journal of lipid research.

[32]  N. Xu,et al.  Expression of apolipoprotein M in human hepatocellular carcinoma tissues. , 2011, Acta histochemica.

[33]  Shuiping Zhao,et al.  Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation. , 2007, Medical hypotheses.

[34]  N. Xu,et al.  Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. , 2003, Acta histochemica.